Disclosed positions
| LIGAND PHARMACEUTICALS INC | LGND | COM NEW | $85,360,737 | 270,052 | SH | None |
| ACI WORLDWIDE INC | ACIW | COM | $50,621,663 | 1,006,595 | SH | None |
| ARLO TECHNOLOGIES INC | ARLO | COM | $50,320,328 | 3,732,962 | SH | None |
| FABRINET | FN | SHS | $49,225,280 | 87,577 | SH | None |
| ESTABLISHMENT LABS HLDGS INC | ESTA | COM | $48,133,832 | 560,935 | SH | None |
| XPO INC | XPO | COM | $46,165,205 | 224,878 | SH | None |
| ZIFF DAVIS INC | ZD | COM | $43,021,746 | 821,496 | SH | None |
| SHIFT4 PMTS INC | FOUR | CL A | $42,535,291 | 874,492 | SH | None |
| KINIKSA PHARMACEUTICALS INTL | KNSA | ORD SHS CL A | $39,964,146 | 624,928 | SH | None |
| ASCENDIS PHARMA A/S | ASND | ORD SHS | $39,646,328 | 148,644 | SH | None |
| STRIDE INC | LRN | COM | $37,857,721 | 438,981 | SH | None |
| PRESTIGE CONSMR HEALTHCARE I | PBH | COM | $32,601,741 | 689,692 | SH | None |
| DONNELLEY FINL SOLUTIONS INC | DFIN | COM | $32,516,242 | 775,119 | SH | None |
| ITURAN LOCATION AND CONTROL | ITRN | SHS | $29,010,011 | 475,496 | SH | None |
| MEDPACE HLDGS INC | MEDP | COM | $28,659,292 | 54,116 | SH | None |
| ARMSTRONG WORLD INDS INC NEW | AWI | COM | $28,417,922 | 177,147 | SH | None |
| GODADDY INC | GDDY | CL A | $28,050,633 | 330,474 | SH | None |
| BIRKENSTOCK HOLDING PLC | BIRK | COM SHS | $27,103,220 | 629,868 | SH | None |
| CLEAR SECURE INC | YOU | COM CL A | $27,029,663 | 485,011 | SH | None |
| INGEVITY CORP | NGVT | COM | $26,224,328 | 351,203 | SH | None |
| WEX INC | WEX | COM | $25,199,521 | 178,606 | SH | None |
| SPORTRADAR GROUP AG | SRAD | CLASS A ORD SHS | $23,917,300 | 1,597,682 | SH | None |
| LIQUIDITY SVCS INC | LQDT | COM | $23,803,581 | 608,476 | SH | None |
| FEDERAL AGRIC MTG CORP | AGM | CL C | $23,532,591 | 118,094 | SH | None |
| BIOCRYST PHARMACEUTICALS INC | BCRX | COM | $23,320,430 | 2,332,043 | SH | None |
| UPWORK INC | UPWK | COM | $23,214,090 | 2,776,805 | SH | None |
| GENPACT LIMITED | G | SHS | $22,934,890 | 833,996 | SH | None |
| SUPERNUS PHARMACEUTICALS | SUPN | COM | $22,800,179 | 490,221 | SH | None |
| VIRIDIAN THERAPEUTICS INC | VRDN | COM | $21,601,393 | 1,175,906 | SH | None |
| RADWARE LTD | RDWR | ORD | $21,011,124 | 680,853 | SH | None |
| ALKERMES PLC | ALKS | SHS | $20,479,424 | 390,866 | SH | None |
| NEXXEN INTL LTD | NEXN | SHS NEW | $19,747,147 | 2,186,838 | SH | None |
| PROGRESS SOFTWARE CORP | PRGS | COM | $19,149,364 | 570,261 | SH | None |
| QUIDELORTHO CORP | QDEL | COM | $18,628,236 | 1,063,559 | SH | None |
| LEMAITRE VASCULAR INC | LMAT | COM | $18,223,476 | 189,907 | SH | None |
| EURONET WORLDWIDE INC | EEFT | COM | $18,128,358 | 247,689 | SH | None |
| LKQ CORP | LKQ | COM | $17,858,559 | 678,259 | SH | None |
| WIX COM LTD | WIX | SHS | $17,359,424 | 382,619 | SH | None |
| NEUROCRINE BIOSCIENCES INC | NBIX | COM | $16,886,364 | 100,195 | SH | None |
| HARROW INC | HROW | COM | $16,459,036 | 387,545 | SH | None |
| OSHKOSH CORP | OSK | COM | $16,270,568 | 106,011 | SH | None |
| VAIL RESORTS INC | MTN | COM | $15,941,123 | 117,085 | SH | None |
| ACADIA PHARMACEUTICALS INC | ACAD | COM | $15,657,841 | 618,887 | SH | None |
| LCI INDS | LCII | COM | $15,105,370 | 142,665 | SH | None |
| VAREX IMAGING CORP | VREX | COM | $15,080,247 | 1,445,853 | SH | None |
| MAXIMUS INC | MMS | COM | $14,994,202 | 278,910 | SH | None |
| BIOMARIN PHARMACEUTICAL INC | BMRN | COM | $14,203,377 | 248,224 | SH | None |
| TAYSHA GENE THERAPIES INC | TSHA | COM SHS | $13,567,079 | 1,992,229 | SH | None |
| BANK OZK LITTLE ROCK ARK | OZK | COM | $13,513,865 | 259,433 | SH | None |
| MIRUM PHARMACEUTICALS INC | MIRM | COM | $12,956,488 | 110,673 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 0 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.